Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosis.
about
Molecular mechanism of aggravation of hypertensive organ damages by short-term blood pressure variabilityRenin-Angiotensin-aldosterone system in diabetes and hypertensionDifferential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis.Histopathological study of time course changes in inter-renal aortic banding-induced left ventricular hypertrophy of mice.Coronary artery remodeling in a model of left ventricular pressure overload is influenced by platelets and inflammatory cells.Molecular determinants of the cardiometabolic phenotype.Differential cardiac remodeling in preload versus afterload.Maternal obesity induces fibrosis in fetal myocardium of sheepModest elevation in BNP in asymptomatic hypertensive patients reflects sub-clinical cardiac remodeling, inflammation and extracellular matrix changes.Granule cargo release from bone marrow-derived cells sustains cardiac hypertrophy.Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cyclic GMP/protein kinase G signaling in cardiac fibroblasts.Optimisation of reference genes for gene-expression analysis in a rabbit model of left ventricular diastolic dysfunction.Prenatal exposure to lipopolysaccharide results in myocardial fibrosis in rat offspring.Dasatinib Attenuates Pressure Overload Induced Cardiac Fibrosis in a Murine Transverse Aortic Constriction ModelEndothelial Nogo-B regulates sphingolipid biosynthesis to promote pathological cardiac hypertrophy during chronic pressure overload.Estrogen therapy, independent of timing, improves cardiac structure and function in oophorectomized mRen2.Lewis rats.Diet reduction to requirements in obese/overfed ewes from early gestation prevents glucose/insulin dysregulation and returns fetal adiposity and organ development to control levels.The Coexistence of Hypertension and Ovariectomy Additively Increases Cardiac ApoptosisBlocking aldosterone in heart failure.Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.The role of mineralocorticoid receptor antagonists (MRAs) in very old patients with heart failure.Mineralocorticoid receptor antagonists for heart failure.Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target.The mononuclear phagocyte system in homeostasis and disease: a role for heme oxygenase-1.Myocyte signalling in leucocyte recruitment to the heart.Cellular Interplay between Cardiomyocytes and Nonmyocytes in Cardiac Remodeling.A Central Role for Monocyte-Platelet Interactions in Heart Failure.Moxonidine improves cardiac structure and performance in SHR through inhibition of cytokines, p38 MAPK and Akt.Elevated Plasma Transforming Growth Factor β1 Levels Predict the Development of Hypertension in Normotensives: The 14-Year Follow-Up Study.Advances in the pharmacotherapy of chronic heart failure with preserved ejection fraction: an ideal opportunity for precision medicine.Attenuation of monocyte chemotaxis--a novel anti-inflammatory mechanism of action for the cardio-protective hormone B-type natriuretic peptide.Cardiosphere-derived cells reverse heart failure with preserved ejection fraction (HFpEF) in rats by decreasing fibrosis and inflammation.Meta-analysis and profiling of cardiac expression modules.The chemokine monocyte chemoattractant protein-1 contributes to renal dysfunction in swine renovascular hypertension.Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes.Pharmacological stimulation of soluble guanylate cyclase modulates hypoxia-inducible factor-1alpha in rat heart.Increased collagen deposition in the heart of chronically hypoxic ovine fetuses.Chronic inhibition of cyclic guanosine monophosphate-specific phosphodiesterase 5 prevented cardiac fibrosis through inhibition of transforming growth factor β-induced Smad signaling.Pressure-independent effects of pharmacological stimulation of soluble guanylate cyclase on fibrosis in pressure-overloaded rat heart.Prognostic significance of hemoglobin level in patients with congestive heart failure and normal ejection fraction.
P2860
Q28085132-17B076E0-6A21-400A-A5C1-102A9A57A4EAQ28308222-E085B2D4-B615-40F7-B2AD-07F4BF91A8C7Q30483132-AC341FE8-0D70-4696-8521-60848BF8AF40Q33270074-972E288B-C0BE-4625-A50C-8C953E63A293Q33402947-9319C615-DEE2-41DD-AD9D-D197C9A6E633Q33921392-2B72BE37-384B-4FE1-BD8E-2FBFE1EE5C61Q34200561-343D985E-9BF6-485F-8A89-1A7F0370BB93Q34425988-5D92FAE1-E2B4-4C90-8CE7-D49D348364CDQ34477882-374538F9-17CA-4B60-9153-34A8B8E42AE0Q34519433-46C6E4C6-F8BC-4683-B42E-03058F208BCCQ34664054-A966C7C9-FB16-478E-AF44-159C33E50C80Q35099855-655F0BB8-9D82-4050-994E-73357F03E86AQ35723587-AA51E475-7249-4774-8D28-50AE0AD2C5A0Q35803480-FB8E1CBA-0848-4F15-95FB-EEBD8199D689Q36867184-6177F802-233C-4FE7-B5DD-DCBF0A64A508Q36948209-676361D9-E151-4EDD-B0DC-E60D71983024Q37234659-DE55F795-2D1B-4239-917A-630C6BA125BDQ37534674-038BF3A2-5B11-49BC-86A0-8B163CE64B6EQ37574673-0807686E-D1DC-4D7B-8D1C-ECC1234CF0ADQ37728377-BF1F1C6F-D2BE-43FF-8C48-D2CA52422BC8Q37945452-BA165B80-9E0B-42D2-8C1A-A496F757F64EQ37955919-E4D2D935-371B-4690-8C03-EA258FFE3C3AQ38134311-3006C644-7364-46C2-8B3C-A04FEFC43136Q38154630-03F0E69B-AD1A-4731-940C-F4ABACB789F9Q38185647-8F59308D-4A98-4B83-AA87-0233A7C9196EQ38509926-E89954B0-D3E7-4258-BCB0-D9AA234FF10DQ38620927-CABCCA91-E2EC-4F1A-99C3-9374F553B56FQ38739980-28BCDB36-BDBB-4533-A617-E4613D250C41Q38748546-4A52EFC0-D1CA-4FC2-AE98-E8570A54744EQ38764956-F90294C9-E580-422E-933E-CC027AE6D4E4Q39159036-B860D63D-683B-455A-B97A-4E2CA4DD9E95Q40286144-E5E33CE3-B6A5-4BE0-9DD6-883D5FD281B7Q41956816-03127F9A-3F1C-4700-992D-F1E06096970BQ42911392-0F59566A-F792-41EE-98B0-C0F24C0A98B1Q43263729-67A92BC5-02CE-4166-AA7A-773BE156C306Q43291189-1A23E2B6-FD3A-44C0-9FE7-554978CFD602Q43714222-63066BE9-E3E3-470D-ACC0-009DB74881E0Q45870342-1BF3AE89-7AAB-4A89-AF84-1D760A06EDCEQ46020956-A3E0582D-084D-4D41-AF3F-3A623759D99CQ46496365-4F10FA81-E754-4EAF-81A4-B3EFBBA0A40F
P2860
Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Diastolic dysfunction in hyper ...... reactive myocardial fibrosis.
@ast
Diastolic dysfunction in hyper ...... reactive myocardial fibrosis.
@en
type
label
Diastolic dysfunction in hyper ...... reactive myocardial fibrosis.
@ast
Diastolic dysfunction in hyper ...... reactive myocardial fibrosis.
@en
prefLabel
Diastolic dysfunction in hyper ...... reactive myocardial fibrosis.
@ast
Diastolic dysfunction in hyper ...... reactive myocardial fibrosis.
@en
P2093
P356
P1476
Diastolic dysfunction in hyper ...... reactive myocardial fibrosis.
@en
P2093
Fumitaka Kuwahara
Hisashi Kai
Keisuke Tokuda
Tsutomu Imaizumi
P2888
P304
P356
10.1291/HYPRES.28.483
P577
2005-06-01T00:00:00Z
P5875
P6179
1049265703